Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG and Cyclosporine in Diamond Blackfan Anemia
NCT00001749Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jul 1998
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin, cyclosporine in Diamond-Blackfan anemia (DBA), sponsored by National Heart, Lung, and Blood Institute. Started Jul 1998; status: completed.
02
Drugs
antithymocyte globulincyclosporine
03
Conditions
Diamond-Blackfan anemia (DBA)
Beyond the preview
Go deeper on NCT00001749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001749.